Clarification

May 06, 2000

In an article in Wednesday's editions, The Sun reported that Orioles radio announcer Chuck Thompson was undergoing "new, experimental therapy" to treat the eye disease macular degeneration.

When Thompson's treatment began earlier this year, the therapy was permitted as part of an experimental study. Since then, on April 12, the Food and Drug Administration approved verteporfin, the drug involved in the therapy, making it no longer experimental.

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.